Cargando…

A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights

Background: Cyclin-dependent kinases (CDKs) regulate mammalian cell cycle progression and RNA transcription. Based on the structural analysis of previously reported CDK2 inhibitors, a new compound with 3-hydrazonoindolin-2-one scaffold (HI 5) was well designed, synthesized, and biologically evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Sanea, Mohammad M., Obaidullah, Ahmad J., Shaker, Mohamed E., Chilingaryan, Garri, Alanazi, Mohammed M., Alsaif, Nawaf A., Alkahtani, Hamad M., Alsubaie, Sultan A., Abdelgawad, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830330/ https://www.ncbi.nlm.nih.gov/pubmed/33466812 http://dx.doi.org/10.3390/molecules26020412

Ejemplares similares

Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies
por: Alanazi, Mohammed M., et al.
Publicado: (2021)

New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies
por: Alanazi, Mohammed M., et al.
Publicado: (2021)

Design, Synthesis and Anticancer Profile of New 4-(1H-benzo[d]imidazol-1-yl)pyrimidin-2-amine-Linked Sulfonamide Derivatives with V600EBRAF Inhibitory Effect
por: Abdel-Maksoud, Mohammed S., et al.
Publicado: (2021)

Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents
por: Eldehna, Wagdy M., et al.
Publicado: (2018)

New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres
por: Attia, Mohamed I., et al.
Publicado: (2017)

Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity
por: Al-Rashood, Sara T., et al.
Publicado: (2020)

Mechanistic interaction study of 5,6-Dichloro-2-[2-(pyridin-2-yl)ethyl]isoindoline-1,3-dione with bovine serum albumin by spectroscopic and molecular docking approaches
por: Alanazi, Mohammed M., et al.
Publicado: (2019)

1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights
por: Al-Warhi, Tarfah, et al.
Publicado: (2023)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
por: Al-Sanea, Mohammad M, et al.
Publicado: (2020)

Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study
por: Abdel-Aziz, Alaa A.-M., et al.
Publicado: (2020)

Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study
por: Shady, Nourhan Hisham, et al.
Publicado: (2021)

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers
por: Alsaif, Nawaf A., et al.
Publicado: (2021)

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers
por: Alanazi, Mohammed M., et al.
Publicado: (2021)

Cancer Chemopreventive Potential and Chemical Profiling of Euphorbia abyssinica Endowed with Docking Studies
por: Ahmed, Shaimaa R., et al.
Publicado: (2022)

Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights
por: Abdelrahman, Mohamed A., et al.
Publicado: (2019)

Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors
por: Al-Sanea, Mohammad M., et al.
Publicado: (2022)

Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery
por: Al-Sanea, Mohammad M., et al.
Publicado: (2021)

Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors
por: Alanazi, Mohammed M., et al.
Publicado: (2023)

Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation
por: Obaidullah, Ahmad J., et al.
Publicado: (2022)

Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2
por: Obaidullah, Ahmad J., et al.
Publicado: (2021)

Validated Microwell-Based Spectrofluorimetric Method for Quantification of Ravidasvir (New Anti-Chronic Hepatitis C Virus-GT4) in Rat Plasma and Its Application to Pharmacokinetic Study
por: Hefnawy, Mohamed, et al.
Publicado: (2020)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
por: Alanazi, Ashwag S., et al.
Publicado: (2023)

Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors
por: El-Azab, Adel S., et al.
Publicado: (2020)

Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide
por: El-Azab, Adel S., et al.
Publicado: (2022)

Endowments
Publicado: (1894)

In Vitro Evaluation and Bioinformatics Analysis of Schiff Bases Bearing Pyrazole Scaffold as Bioactive Agents: Antioxidant, Anti-Diabetic, Anti-Alzheimer, and Anti-Arthritic
por: Alkahtani, Hamad M., et al.
Publicado: (2023)

Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery
por: Al-Sanea, Mohammad M., et al.
Publicado: (2021)

Deeper Insights on Cnesmone javanica Blume Leaves Extract: Chemical Profiles, Biological Attributes, Network Pharmacology and Molecular Docking
por: Obaidullah, Ahmad J., et al.
Publicado: (2021)

Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids
por: Alanazi, Ashwag S., et al.
Publicado: (2023)

New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches
por: Alsfouk, Aisha A., et al.
Publicado: (2023)

Synthesis and biological evaluation of small molecule modulators of CDK8/Cyclin C complex with phenylaminoquinoline scaffold
por: Al-Sanea, Mohammad M.
Publicado: (2020)

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
por: Hamdi, Abdelrahman, et al.
Publicado: (2023)

Endowed Research
Publicado: (1909)

The Endowment of Research
Publicado: (1902)

The Endowment of Research
Publicado: (1903)

The Art of Endowment
Publicado: (1918)

The Endowment of Research
Publicado: (1898)

The Endowment of Motherhood
Publicado: (1919)

PH motifs in PAR(1&2) endow breast cancer growth
por: Kancharla, A., et al.
Publicado: (2015)

Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors
por: Chilingaryan, Garri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6s3eq7sqrk889e7hrfgv1svcof